Nigerian 100K Genome Project (Non-Communicable Diseases Genetic Heritage Study, NCD-GHS)

About this cohort

Launched in 2020 as a public-private consortium led by 54gene's non-profit African Center for Translational Genomics (ACTG). Aims to sequence 100,000 adult Nigerians spanning 300+ ethnic groups to build a comprehensive catalogue of African human genetic variation. Recruitment ~60–100% complete by 2022; investigates the genetic basis of NCDs (cancer, cardiovascular, diabetes, sickle cell, Alzheimer's). Initial sample size of 449 in the workbook likely refers to a pilot subset.

Research themes

Primary research themes for this cohort.

Study population

Who the cohort follows.

This cohort covers 449 participants in a mixed setting in Nigeria, spanning Adults (all). Detailed inclusion criteria and follow-up schedule — To be confirmed.

Timeline

Milestones in the cohort record.

Key characteristics

Core descriptive metadata.

Institutions & governance

Lead institution(s); partners and governance to be confirmed.

Partner institutions & governance arrangements — To be confirmed

Nested studies & sub-cohorts

Studies built on this cohort platform.

FAIR readiness

Findable, Accessible, Interoperable, Reusable assessment.

Investigators

Principal investigators and ORCID identifiers.

Data access & governance

How the data can be accessed and governed.

Collaboration opportunities

Partnerships and capacity strengthening.

Contact

How to reach the cohort team or request access.